For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220907:nRSG5160Ya&default-theme=true
RNS Number : 5160Y Avon Protection PLC 07 September 2022
7 September 2022
Avon Protection plc
("Avon Protection" or "the Group")
Order announcement and trading update
Avon Protection today provides the following order announcement and a brief
update on trading in the second half of its financial year ending 30 September
2022.
The Group is pleased to announce the receipt of an order for c.380,000 pairs
of M61 filters worth $15.1 million from the U.S. Department of Defense.
Deliveries under this order are expected to commence in early FY23.
Trading in the second half of FY22 has improved in line with management's
expectations as set out at the half year results in May. This is due to a
modest improvement in mix in our respiratory portfolio and the commencement of
body armor deliveries following achievement of full FAT approval, which
partially offset the negative headwinds seen in H1. In addition, cost
reduction activities continue to progress as expected. Overall, performance
for the year on an excluding armor basis is predicted to be at least in line
with market expectations.
Following Paul McDonald's decision to step down as CEO at the end of
September, which was announced in May, the Group can confirm that the search
for his successor is making good progress.
For further enquiries, please contact:
Avon Protection +44 1225 896 848
Paul McDonald, Chief Executive Officer
Rich Cashin, Chief Financial Officer
Rory Wiltshire, Investor Relations Manager
MHP Communications +44 771 003 2657
Andrew Jaques avonprotection@mhpc.com
Charlie Barker
Pete Lambie
Legal Entity Identifier: 213800JM1AN62REBWA71
The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulation
("MAR") EU no.596/2014. Upon the publication of this announcement via
Regulatory Information Service ("RIS"), this inside information is now
considered to be in the public domain.
Note to editors:
Avon Protection designs and produces life-critical personal protection
solutions for the world's militaries and first responders. With a portfolio
that includes Chemical, Biological, Radiological, Nuclear ("CBRN"),
respiratory and head protection products, our mission is to enhance the
performance, efficiency and capability of our customers whilst providing ever
increasing levels of protection.
Avon Protection operates from six sites employing approximately 1,000 people
and is listed on the London Stock Exchange (LSE: AVON).
For further information, please visit our website www.avon-protection-plc.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TSTDGGDCISGDGDL